Tseneva G Ia, Bondarenko V M, Voskresenskaia E A, Kuliashova L B
Zh Mikrobiol Epidemiol Immunobiol. 1994 Jul-Aug(4):45-8.
Samples of Y.pseudotuberculosis (serovar I) antigens, represent a high-molecular lipopolysaccharide (LPS) fraction with a mol. wt. of 22.5 kD and fractions of outer membrane proteins isolated by the method of M. Osborn and R. Munson (1974), were tested in comparison with the activity with live cells of Y. pseudotuberculosis I attenuated mutant KV 9/2, having lost its Cad plasmid of virulence with a mol. wt. of 47 MD and carrying 2 attenuating markers: resistance to crystal violet and nalidixic acid. In experiments on guinea pigs pathomorphological studies demonstrated high protective activity of Y.pseudotuberculosis I attenuated mutant KV 9/2 and a pronounced protective effect achieved after the immunization of the animals with complex biopolymers, including a high-molecular LPS fraction and outer membrane proteins.
对假结核耶尔森菌(血清型I)抗原样本进行了测试,该样本代表一种分子量为22.5 kD的高分子脂多糖(LPS)组分以及通过M.奥斯本和R.芒森(1974年)方法分离的外膜蛋白组分,并与失去分子量为47 MD的毒力Cad质粒且携带两个减毒标记(对结晶紫和萘啶酸耐药)的假结核耶尔森菌I减毒突变株KV 9/2的活细胞活性进行了比较。在豚鼠实验中,病理形态学研究表明假结核耶尔森菌I减毒突变株KV 9/2具有很高的保护活性,并且在用包括高分子LPS组分和外膜蛋白的复合生物聚合物对动物进行免疫后可获得显著的保护效果。